Village-Integrated Eye Worker Trial II
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Nov 21, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Village-Integrated Eye Worker Trial II is studying two different ways to prevent blindness caused by eye diseases like age-related macular degeneration, diabetic retinopathy, and glaucoma in Nepal. The goal is to find out which method works better: one that uses advanced technology to screen for these conditions, or a simpler approach that only checks how well people can see. Researchers will gather information about people's vision before starting the programs and then check again four years later to see if there's a difference in vision outcomes.
To participate in this trial, individuals must be 60 years or older and live in certain areas near the Bharatpur Eye Hospital or Lumbini Eye Institute. They also need to be willing to take part in the study. The trial is currently recruiting participants, and it aims to help improve eye care in communities that have a high number of undiagnosed eye issues. This research could eventually lead to better eye care strategies that could be used in other parts of the world.
Gender
ALL
Eligibility criteria
- • Community level
- Inclusion Criteria:
- • Located in catchment area of Bharatpur Eye Hospital or Lumbini Eye Institute
- • Accessible by non-4WD vehicle
- • Urban or peri-urban
- Exclusion Criteria:
- • - Local leaders unwilling to participate
- • Person level
- Inclusion Criteria:
- • 50 years and older
- • Residing in the community during the time of the census
- Exclusion Criteria:
- • - Unwilling to participate
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bharatpur, Chitwan, Nepal
Bhairahawa, , Nepal
Patients applied
Trial Officials
Jeremy Keenan
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials